200 related articles for article (PubMed ID: 34963495)
1. The role of vascular endothelial growth factor as a prognostic and clinicopathological marker in osteosarcoma: a systematic review and meta-analysis.
Zhang C; Wang L; Xiong C; Zhao R; Liang H; Luo X
J Orthop Surg Res; 2021 Dec; 16(1):738. PubMed ID: 34963495
[TBL] [Abstract][Full Text] [Related]
2. A systematic review of vascular endothelial growth factor expression as a biomarker of prognosis in patients with osteosarcoma.
Chen D; Zhang YJ; Zhu KW; Wang WC
Tumour Biol; 2013 Jun; 34(3):1895-9. PubMed ID: 23589053
[TBL] [Abstract][Full Text] [Related]
3. The prognostic value of elevated vascular endothelial growth factor in patients with osteosarcoma: a meta-analysis and systemic review.
Qu JT; Wang M; He HL; Tang Y; Ye XJ
J Cancer Res Clin Oncol; 2012 May; 138(5):819-25. PubMed ID: 22274866
[TBL] [Abstract][Full Text] [Related]
4. Vascular endothelial growth factor expression in untreated osteosarcoma is predictive of pulmonary metastasis and poor prognosis.
Kaya M; Wada T; Akatsuka T; Kawaguchi S; Nagoya S; Shindoh M; Higashino F; Mezawa F; Okada F; Ishii S
Clin Cancer Res; 2000 Feb; 6(2):572-7. PubMed ID: 10690541
[TBL] [Abstract][Full Text] [Related]
5. Effects of vascular endothelial growth factor expression on pathological characteristics and prognosis of osteosarcoma.
Han G; Wang Y; Bi W; Jia J; Wang W; Xu M
Clin Exp Med; 2016 Nov; 16(4):577-584. PubMed ID: 26319790
[TBL] [Abstract][Full Text] [Related]
6. Impact of vascular endothelial growth factor expression on overall survival in patients with osteosarcoma: a meta-analysis.
Zhuang Y; Wei M
Tumour Biol; 2014 Mar; 35(3):1745-9. PubMed ID: 24515658
[TBL] [Abstract][Full Text] [Related]
7. Prognostic impact of blood and urinary angiogenic factor levels at diagnosis and during treatment in patients with osteosarcoma: a prospective study.
Tabone MD; Brugières L; Piperno-Neumann S; Selva MA; Marec-Bérard P; Pacquement H; Lervat C; Corradini N; Gentet JC; Couderc R; Chevance A; Mahier-Ait Oukhatar C; Entz-Werle N; Blay JY; Le Deley MC
BMC Cancer; 2017 Jun; 17(1):419. PubMed ID: 28619014
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of VEGF expression in osteosarcoma: a meta-analysis.
Yu XW; Wu TY; Yi X; Ren WP; Zhou ZB; Sun YQ; Zhang CQ
Tumour Biol; 2014 Jan; 35(1):155-60. PubMed ID: 23907576
[TBL] [Abstract][Full Text] [Related]
9. Role of vascular endothelial growth factor as a tumour marker in osteosarcoma: a prospective study.
Rastogi S; Kumar R; Sankineani SR; Marimuthu K; Rijal L; Prakash S; Jalan D; Khan SA; Sharma MC
Int Orthop; 2012 Nov; 36(11):2315-21. PubMed ID: 23015149
[TBL] [Abstract][Full Text] [Related]
10. Correlation of vascular endothelial growth factor with survival and pathological characteristics of patients with osteosarcoma: A systematic review and meta-analysis.
Xin S; Wei G
Eur J Cancer Care (Engl); 2022 Sep; 31(5):e13629. PubMed ID: 35707976
[TBL] [Abstract][Full Text] [Related]
11. Investigating the Relationship between of Vascular Endothelial Growth Factor and HER-2neu in IHC Staining with Metastasis and Mortality in Patients with Osteosarcoma.
Aznab M; Khajevand Ahmady M; Jamshidi K; Madani SH; Khazaei S; Shoushtaryzadeh T; Bagheri A
Asian Pac J Cancer Prev; 2020 Oct; 21(10):3005-3009. PubMed ID: 33112560
[TBL] [Abstract][Full Text] [Related]
12. Relationships between levels of CXCR4 and VEGF and blood-borne metastasis and survival in patients with osteosarcoma.
Lin F; Zheng SE; Shen Z; Tang LN; Chen P; Sun YJ; Zhao H; Yao Y
Med Oncol; 2011 Jun; 28(2):649-53. PubMed ID: 20349215
[TBL] [Abstract][Full Text] [Related]
13. Transferrin receptor-1 and VEGF are prognostic factors for osteosarcoma.
Wu H; Zhang J; Dai R; Xu J; Feng H
J Orthop Surg Res; 2019 Sep; 14(1):296. PubMed ID: 31484533
[TBL] [Abstract][Full Text] [Related]
14. Neoadjuvant multidrug chemotherapy including high-dose methotrexate modifies VEGF expression in osteosarcoma: an immunohistochemical analysis.
Rossi B; Schinzari G; Maccauro G; Scaramuzzo L; Signorelli D; Rosa MA; Fabbriciani C; Carlo B
BMC Musculoskelet Disord; 2010 Feb; 11():34. PubMed ID: 20158913
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA MALAT1 as a valuable biomarker for prognosis in osteosarcoma: A systematic review and meta-analysis.
Liu M; Yang P; Mao G; Deng J; Peng G; Ning X; Yang H; Sun H
Int J Surg; 2019 Dec; 72():206-213. PubMed ID: 31734255
[TBL] [Abstract][Full Text] [Related]
16. Caveolin-1 Expression Together with VEGF can be a Predictor for Lung Metastasis and Poor Prognosis in Osteosarcoma.
Mohamed FEA; Khalil EZI; Toni NDM
Pathol Oncol Res; 2020 Jul; 26(3):1787-1795. PubMed ID: 31676993
[TBL] [Abstract][Full Text] [Related]
17. High expression levels of Cyr61 and VEGF are associated with poor prognosis in osteosarcoma.
Liu Y; Zhang F; Zhang Z; Wang D; Cui B; Zeng F; Huang L; Zhang Q; Sun Q
Pathol Res Pract; 2017 Aug; 213(8):895-899. PubMed ID: 28647210
[TBL] [Abstract][Full Text] [Related]
18. Expression of Vascular Endothelial Growth Factor correlates with the advance of clinical osteosarcoma.
Lammli J; Fan M; Rosenthal HG; Patni M; Rinehart E; Vergara G; Ablah E; Wooley PH; Lucas G; Yang SY
Int Orthop; 2012 Nov; 36(11):2307-13. PubMed ID: 22855059
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathologic significance and prognostic value of circRNAs in osteosarcoma: a systematic review and meta-analysis.
Zhong J; Zhang G; Yao W
J Orthop Surg Res; 2021 Oct; 16(1):578. PubMed ID: 34620208
[TBL] [Abstract][Full Text] [Related]
20. Quantitative assessment of the association of COX-2 (Cyclooxygenase-2) immunoexpression with prognosis in human osteosarcoma: a meta-analysis.
Wang Z; He M; Xiao Z; Wu H; Wu Y
PLoS One; 2013; 8(12):e82907. PubMed ID: 24358237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]